Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Mon, 08.01.2024
Evotec SE
KEY SCIENTIFIC ACHIEVEMENT ADVANCES THE JOINT NEUROSCIENCE PIPELINE AND EARNS A PAYMENT OF US$ 25 M TO EVOTEC TO PROGRESS FURTHER RESEARCH
Hamburg, Germany, 08 January 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced progress within the Company’s strategic partnership with Bristol Myer [ … ]
Mon, 08.01.2024
Northern Data AG
PRESS RELEASE / IR NEWS
Northern Data Group announces closing of Damoon acquisition
Major progress in the execution of Northern Data Group‘s vision to become the world’s leading High-Performance Computing (HPC) Infrastructure Solutions Provider
Northern Data Group now owns 100% of Damoon
Aroosh Thillainathan, Founder and CEO, has announced tha [ … ]
Fri, 05.01.2024
STEICO SE
Changes to the Administrative Board of STEICO SE as part of the sale of the majority shares in STEICO SE.
Feldkirchen near Munich, 5 January 2024 – (ISIN DE000A0LR936) – As already stated in the ad hoc announcement of 17 July 2023, the sale of the majority shares in STEICO SE by Schramek GmbH to the Irish Kingspan Group will result in changes to t [ … ]
Fri, 05.01.2024
Mutares SE & Co. KGaA
First exit in 2024: Mutares has successfully sold VALTI to the company’s management
Munich, January 5, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has successfully sold its portfolio company VALTI to the company’s management.
VALTI is a European manufacturer of seamless high-precision steel tubes serving the bearing manufacturer industr [ … ]
Fri, 05.01.2024
CureVac
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
Head-to-head comparison with licensed bivalent mRNA-based comparator vaccine confirms competitive immune responses at lower doses and favorable tolerability profile
M [ … ]
Fri, 05.01.2024
Immunic, Inc.
Immunic Highlights 2023 Accomplishments and Upcoming Milestones
– Evidence for Neuroprotective Activity of Vidofludimus Calcium from Phase 2 CALLIPER Interim Analysis, Consistent Across the Entire Progressive Multiple Sclerosis Population and All Subtypes –
– Phase 3 ENSURE Program in Relapsing Multiple Sclerosis Ongoing –
– Improvements in Gut [ … ]
Fri, 05.01.2024
Immunic, Inc.
Immunic, Inc. Announces Private Placement of up to $240 Million
NEW YORK, January 5, 2024 – Immunic, Inc. (Nasdaq: IMUX) (“Immunic” or the “Company”), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced it has entered into a securi [ … ]
Fri, 05.01.2024
Cherry SE
Nicole Schillinger is joining Cherry SE as Senior Vice President Investor Relations
Munich, January 5, 2024 – As of January 1, 2024, Nicole Schillinger took over responsibility for Investor Relations at Cherry SE [ DE000A3CRRN9] in a new role.
She takes over the position from Dr. Kai Holtmann, who would like to take on new professional challenges [ … ]
Fri, 05.01.2024
AGI Technology
EQS-Media / 05.01.2024 / 09:30 CET/CEST
The Supreme Pro TF138 2TB microSD card
As 2023 concludes, AGI Technology, a proud Taiwanese storage brand, is set to elevate the storage product market with an unprecedented release. Shattering the world's maximum capacity records for microSD cards, they unveil a memory card that harmonizes top-notch [ … ]
Fri, 05.01.2024
Nordea Bank Abp
Nordea Bank Abp
/ Key word(s): Share Buyback
Transaction in Own Shares
05.01.2024 / 08:00 CET/CEST
Nordea Bank Abp: Repurchase of own shares on 04.01.2024
Nordea Bank Abp
Stock exchange release - Changes in company's own shares
04.01.2024 at 22.30 EET
Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 04.01.2024 compl [ … ]